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Age-related macular degeneration (ARMD) is the leading cause of vision loss in
developed countries. Hallmarks of the disease are well known; indeed, this pathology
is characterized by lipofuscin accumulation, is principally composed of lipid-containing
residues of lysosomal digestion. The N-retinyl-N-retinylidene ethanolamine (A2E) retinoid
which is thought to be a cytotoxic component for RPE is the best-characterized
component of lipofuscin so far. Even if no direct correlation between A2E spatial
distribution and lipofuscin fluorescence has been established in aged human RPE,
modified forms or metabolites of A2E could be involved in ARMD pathology.
Mitogen-activated protein kinase (MAPK) pathways have been involved in many
pathologies, but not in ARMD. Therefore, we wanted to analyze the effects of A2E on
MAPKs in polarized ARPE19 and isolated mouse RPE cells. We showed that long-term
exposure of polarized ARPE19 cells to low A2E dose induces a strong decrease of
the extracellular signal-regulated kinases’ (ERK1/2) activity. In addition, we showed
that A2E, via ERK1/2 decrease, induces a significant decrease of the retinal pigment
epithelium-specific protein 65 kDa (RPE65) expression in ARPE19 cells and isolated
mouse RPE. In the meantime, we showed that the decrease of ERK1/2 activity mediates
an increase of basic fibroblast growth factor (bFGF) mRNA expression and secretion
that induces an increase in phagocytosis via a paracrine effect. We suggest that the
accumulation of deposits coming from outer segments (OS) could be explained by both
an increase of bFGF-induced phagocytosis and by the decrease of clearance by A2E.
The bFGF angiogenic protein may therefore be an attractive target to treat ARMD.
Keywords: retinal metabolism, A2E, age-related macular degeneration (ARMD), ARPE19, retinal pigment
epithelium cells (RPE), fibroblast growth factor (FGF), mitogen-activated protein kinase (MAPK), extracellular
signal-regulated kinase (ERK)
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INTRODUCTION
ARMD is the most significant cause of blindness in individuals
over 50 years of age. This pathology is defined by the presence
of drusens, hyper- and hypo-pigmentation of retinal pigment
epithelium (RPE) cells, RPE and photoreceptor apoptosis and
choroidal neovascularization (CNV). There are two subgroups
of ARMD that are classically distinguished: the dry form
(geographic atrophy) and thewet form (exudative). The dry form
is characterized by the formation of drusen (extracellular debris
and deposits) between the RPE cells and Bruch’s membrane.
This accumulation is toxic for RPE cells, which serve metabolic
and supportive functions that are vital for retinal photoreceptors
(Fine et al., 2000). The most important functions of RPE
are (1) the regeneration of the bleached visual pigment (all-
trans retinol to 11-cis retinal) allowing it to re-enter the visual
cycle, (2) the maintenance of the interphotoreceptor matrix and
Bruch’s membrane, (3) the transport of oxygen, water, ions, and
nourishment from the choroid vessels to the outer layers of the
retina and (4) the phagocytic uptake and degradation of apical
photoreceptor outer segments (OS) (for review see Lehmann
et al., 2014). Drusen deposits are principally composed of
lipofuscin resulting from free 11-cis-retinal that is continuously
supplied to the rods for rhodopsin regeneration and outer
segment renewal, and this altered material is trapped in the cell
(Boyer et al., 2012). The N-retinyl-N-retinylidene ethanolamine
(A2E) retinoid is the best-characterized constituent of lipofuscin
and thought to be a cytotoxic component. Despite the fact that
a recent study did not show any direct correlation between A2E
and lipofuscin localization in human RPE (Ablonczy et al., 2013),
it remains interesting to study the effects of this compound
on RPE cells, because metabolites or modified forms of A2E
could be involved in ARMD pathology. Moreover, A2E has a
broad band absorption spectrum, with a peak in the blue range
(∼430 nm), therefore it is a potent photo-inducible generator
of reactive oxygen species (ROS) which can damage proteins,
lipids and DNA of RPE cells (Iriyama et al., 2008) leading to an
impairment of RPE cell functions and to apoptosis (Suter et al.,
2000). Importantly, A2E has been implicated in the activation of
the complement system (Zhou et al., 2006) and in the induction
of the vascular endothelial growth factor (VEGF) expression
and secretion by RPE cells. This regulation occurs through the
transactivation of the retinoic acid receptor (RAR) (Iriyama
et al., 2008). As VEGF is thought to play a major role in the
neovascularization which occurs in the later stage of ARMD, the
accumulation of lipofuscin could be related to an increased risk
of CNV (de Jong, 2006; Nowak, 2006). In addition, A2E inhibits
retinoid isomerohydrolase activity by direct interaction with the
retinal pigment epithelium-specific protein 65 kDa (RPE65), a
key protein in the visual cycle (Moiseyev et al., 2010).
Fibroblast growth factor-2 (FGF2), also termed basic FGF
(bFGF), is a member of the large FGF family. It fulfills numerous
diverse functions, including stimulation of muscle cell growth,
wound healing and tissue repair, and may play key roles in the
nervous system, eye and skeleton (for review see Bikfalvi et al.,
1997; Ornitz and Itoh, 2001). This angiogenic factor is expressed
in almost all retinal cells and more interestingly in RPE cells
(Bost et al., 1992). Three bFGF isoforms have been described in
rodents (18, 21, and 23 kDa) and despite the lack of secretory
signal peptide; the lower molecular weight isoform (18 kDa) is
secreted, while highermolecular weight isoforms (21 and 23 kDa)
are translocated to the nucleus. These isoforms have different
subcellular localizations and functions (for review see Sørensen
et al., 2006). The lower molecular weight isoform of bFGF (18
kDa) plays a role in cell growth and migration, in an autocrine
manner. On the other hand, higher molecular weight isoforms
of bFGF are principally involved in cell growth processes
without affecting migration (for review see Bikfalvi et al., 1997).
Secreted bFGF binds to heparin sulfate that first stabilizes the
protein, besides creating a pool of angiogenic growth factors
susceptible to be mobilized directly from the extracellular matrix
to target cells (Powers et al., 2000). The release of bFGF
occurs by exocytosis or by salting-out from damaged cells
(Mignatti et al., 1992; Venuta et al., 2015). In addition to its
angiogenic function, bFGF accomplishes autocrine and paracrine
functions. In the retina, bFGF protects photoreceptors from light
damage (Faktorovich et al., 1992), enhances the RPE phagocytic
competence (McLaren and Inana, 1997; Sakuragi et al., 2001),
induces retinal regeneration (Sakaguchi et al., 1997) and protects
against photoreceptor degeneration (Faktorovich et al., 1990). On
account of its presence in the interphotoreceptor matrix and RPE
cells, it may protect the neural retina by regulating nitric oxide
production (Goureau et al., 1993). In addition, bFGF has also
been implicated in the up-regulation of VEGF, a key molecule in
ARMD pathology (Seghezzi et al., 1998).
The human genome encodes 518 protein kinases, the so-called
“kinome” (Manning et al., 2002). Our cells receive a wide range of
stimuli and the activation of signal transduction cascades allows
the cells to respond to all these divergent inputs in order to
facilitate their adaptation to new environmental conditions. By
phosphorylating substrate proteins, kinases modify the activity,
the location and the affinities of up to 30% of all cellular
proteins, and direct most cellular processes, particularly in signal
transduction, and coordination of complex pathways. Recent
reviews have highlighted the key roles of these protein kinases in
numerous human diseases including inflammatory (rheumatoid
arthritis, multiple sclerosis, asthma, inflammatory bowel disease,
and psoriasis), neurodegenerative (Alzheimer’s, Parkinson’s and
Huntington’s diseases, stroke), metabolic (obesity, type 1, and
2 diabetes), and oncologic diseases (for review see Kim and
Choi, 2010). The MAPKs (Mitogen-Activated Protein Kinases)
are composed of three conserved kinases that proceed through a
phosphorylation cascade creating a sequential activation pathway
(Widmann et al., 1999). In mammals, three major MAPKs have
been well described: (1) the ERK1/2/3 (Extracellular signal-
Regulated Kinases 1-3; Davis, 1995), (2) the p38 kinases (P38
α/β/δ, and P38 g also named Erk6) (Enslen et al., 2000) and
(3) the JNK1/2/3 (c-Jun N-terminal Kinases 1-3 Davis, 1994).
Whereas, the ERKs are preferentially activated by growth
factors and mitogens, the p38 kinases and JNKs primarily
respond to a variety of stimuli collectively designated as “stress
signals.” These include UV exposure, osmotic shocks and
cytokine treatments (IL-1β, TNFα) and are associated with
major changes in cell fate including growth arrest, apoptosis
and activation of immune cells (for review see Pearson et al.,
2001).
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Within this study, we show that the polarization of ARPE19
cells (cultured on transwells vs. plastic plates) affects basal
MAPK activity. Moreover, we first confirmed that A2E bis-
retinoid is a toxic compound that induces ARPE19 cell death and
describe for the first time that A2E modulates MAPK activities
in polarized ARPE19 cells. While A2E rapidly activated the JNK
pathway, the compound did not affect p38 and ERK1/2 pathways.
Contrariwise, long-term exposure to A2E induced a significant
decrease of ERK1/2, with no modification of p38 and JNK
activities. A2E also decreased ERK1/2 activity in isolated mouse
RPE, and in addition down-regulated the protein expression
of RPE65. A2E drastically increased bFGF mRNA expression
through the inhibition of ERK1/2, and seemed to promote bFGF
secretion. Interestingly, bFGF was able to down-regulate ERK1/2
activity in polarized ARPE19 cells and promoted phagocytosis.
We point out, for the first time, that A2E induces bFGF, an
angiogenic factor that could play an important role in ARMD
pathology. Therefore, bFGF could be, as well as VEGF, another
interesting target in order to treat ARMD.
MATERIALS AND METHODS
Mouse Line
This study adhered to the Association for Research in Vision
and Ophthalmology (ARVO) statement for the use of animals
in ophthalmic and vision research and was approved by the
Veterinary service of the State of Valais, Switzerland (permit ID:
VS22). Animals were kept in a 12-h light/12-h dark cycle with
unlimited access to food and water. Mice were killed by cervical
dislocation followed by exsanguination just after eye enucleation
and retina isolation.
A2E Synthesis
A2E was synthesized following the protocol proposed by Parish
et al. (1998), briefly all-trans-retinal (100 mg, 0.352 mmol, 2.0
equiv) was added to a solution of ethanolamine (9.5 mg, 0.155
mmol, 0.9 equiv) and acetic acid (9.3 ml, 155 mmol, 0.9 equiv) in
3.0 ml of ethanol. The mixture was stirred at room temperature
in the dark for 44 h. The deep red solution was directly
chromatographed without evaporation on a silica gel column
(25 mm∗20 cm), first eluting with 300 ml of CH2Cl2/MeOH
(95:5 v/v), then with 300 ml of CH2Cl2/MeOH/CF3COOH
(90:10:0.001 v/v). A2E was isolated from the dark orange
fractions eluting immediately after the solvent change. The last
fractions contained impurities and were discarded. The pure
fractions (checked by LC-MS) contained 76.5mg of A2E (0.108
mmol, 31%). 1H-NMR (CD3OD) was identical to published
values (Parish et al., 1998). A2E was aliquoted, lyophilized and
stored at −20◦C in the dark. Prior to each experiment, A2E was
reconstituted in ethanol (EtOH) and concentration assessed by
near-UV (430 nm) aborption value as described by Parish et al.
(1998).
Isolated Primary RPE and ARPE19 Culture
Conditions
Primary RPE cells were obtained from isolated Retinas of 12
day-old C57BL/6 mice as previously described (Bonilha et al.,
1999; Nandrot et al., 2004); briefly the eyes were dissected and
placed directly in calcium- and magnesium-free Hank’s buffered
salt solution (HBSS) (Gibco, 14175-053). The cornea, lens, iris,
and vitreous body were removed and eyes were treated with
1 mg/ml hyaluronidase (Sigma, H3506 451 U/mg) for 45 min
at 37◦C, in HBSS. Then, the eyecups were transferred into
HBSS and the retina removed. Eyecups with exposed RPE were
incubated for 45 min at 37◦C in 2 mg/ml trypsin (Gibco, 27250-
018) in HBSS containing calcium andmagnesium (Gibco, 14065-
049). Following digestion, they were transferred into calcium-
and magnesium-free HBSS and patches of RPE were peeled
off manually from the Bruch’s membrane. These RPE sheets
were removed from the underlying choroid with dissecting
forceps and needles, then carefully collected and stored in a very
small volume of HBSS. Afterwards, RPE sheets were incubated
for 1 min at 37◦C with trypsin/EDTA 0.25% (Sigma, T4049).
Then, the cells were centrifuged at 1′000 rpm during 5 min,
supernatant was discarded and cells resuspended in DMEM
F12 medium (Gibco, 31330-095) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) (Lonza, #DE14-801F) and
1% penicillin/streptomycin (Gibco, 10378-016); and then plated
on 12- or 6-well plates (Milian, TP-92412 or -06) for 5 days at
37◦C before any treatment. Six eyes were needed per well of
12-well plates.
ARPE19 and isolated RPE cells were cultured on transwell
filters (Corning R© Transwell R© polyester; Sigma, CLS3450-24EA;
Dunn et al., 1996; Kannan et al., 2006), treated for 60 min at
RT with 1% laminin (Sigma, L2020) in DMEM F12 without
serum. Cells were seeded at a density of 500′000 cells/transwell
and cultured for 3 days in DMEM F12 supplemented with
10% FBS and 1% penicillin/streptomycin (Gibco). Afterwards
cells were cultured 4 weeks before treatment, in DMEM F12
supplemented with 1% FBS. ARPE19 cells were also cultured
on plastic wells to confluence in DMEM F12 supplemented
with 10% heat inactivated FBS for 1 month as previously
described (Roduit and Schorderet, 2008). Isolated mouse RPE
or ARPE19 cells were cultured in presence or absence of 5 µM
A2E (protected from light), 200 ng/ml bFGF (Sigma, F0291)
and 10 µM U0126 (Sigma, U120-1 mg) ERK1/2 inhibitor, for
different periods of time prior mRNA or protein extraction
for analysis. In major experiments, ARPE19 were cultured for
72 h in presence of A2E, then the medium was changed and
cells further cultured for another 72 h period without A2E.
For Cycloheximide (Santa Cruz Biotechnology, sc-3508) and
Actinomycin (Sigma, A5156-1VL) experiments on bFGF mRNA
expression, ARPE19 were prepared on filters as described above
and then cultured for 48 h in absence or in presence of 5
µM A2E, with or without 10 µg/ml Cycloheximide or 5 µg/ml
Actinomycin.
Concerning phagocytosis analysis, ARPE19 cells were grown
to confluence on 0.1% gelatin-coated glass coverslips in
DMEM F12 supplemented with 10% FBS. Then, the cells
were supplemented with various additives to challenge their
phagocytosis ability. A2E treatment was performed as described
above, and prior phagocytosis assay, 5 µM U0126 was added
for 24 h at 37◦C, where cells were protected from light and
200 ng/ml bFGF was added into the media for 24 h at 37◦C.
Finally Merocyanine 540 (MC540) [Sigma, 323756] was used at
a concentration of 4.5 µM in serum-free cell culture medium
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for 1 h at 37◦C, then washed 3 times with PBS and irradiated
for 30 min with a green range light (Philips TLD 18W/17). After
irradiation, the cells were incubated for 24 h with fresh medium
at 37◦C.
Western Blot Analysis and Immunostaining
Thirty µg of total proteins were separated on acrylamide gels
(10–12%) and electrically transferred onto PVDF filters. The
membranes were then incubated with the following antibodies
from Cell Signaling: anti-phospho-JNK (#4668), anti-phospho-
p44/42 MAPK (Erk1/2) (4377S), anti-phospho-p38 (9211S) and
anti-p38 (9212); from Abcam: anti-Erk2 (ab7948), anti-type 1
collagen (ab34710) and anti-RPE65 (ab13826); from Sigma: anti-
bFGF (SAB3300013) and anti-alpha-tubulin (T5168); from Santa
Cruz Biotechnology: anti-JNK (sc-571). We used AlexaFluor R©
594 as secondary antibodies, either goat anti-mouse IgG
(H+L) (LubioScience GmbH, A-11005) or goat anti-rabbit
IgG (LubioScience GmbH, A11012) depending on the primary
antibody used. All western blot analyses were performed under
denaturing conditions, except for type 1 collagen detection
where the native condition was kept, using tris-glycine migration
buffer without SDS and commercial non-denaturing precast gel
(BioRad, M062211A1). A protein ladder (Li-COR, 928-40000)
was used to confirm the correct size of the proteins of interest.
Immunostaining for ZO-1 was done using anti-ZO-1 from
Invitrogen (617300). ARPE19 cells were cultured as described
above and then fixed with 4% paraformaldehyde (Acros Orga,
41678-0010) for 1 h at RT. After three successive washes of 10
min with PBS, the cells were permeabilized with 0.1% Triton
X100 for 30 min at RT, and then incubated in blocking buffer (5%
NGS (Sigma, G9023) for 1 h at RT, prior their incubation with
anti-ZO-1 O/N at 4◦C. An AlexaFluor R© 594 goat anti-rabbit IgG
was chosen as secondary antibody. Immunostaining for bFGF
was performed without the permeabilization step in order to
detect external bFGF; briefly the cells were cultured and treated
as described above, fixed with 2% paraformaldehyde at the end
of the experiment and incubated O/N at 4◦C with anti-bFGF
antibody (Sigma, F3393), and AlexaFluor R© 594 goat anti-rabbit
IgG was used as secondary antibody. Fluorescence was visualized
under microscope (Leica) using appropriate filters.
Cell Death Analysis
ARPE19 cell apoptosis was assessed after various periods of time
(5, 72, and 72+ 72 h recovery) by staining with propidium iodide
(Sigma, 81845-25 MG) and Hoechst 33342 (Sigma, B2261-25
MG). Apoptotic cells exhibited a condensed nuclear chromatin or
a fragmented nuclear membrane when visualized with Hoechst
33,342. Necrotic cells were stained with propidium iodide at
1/2’000 dilution for 5 min at 37◦C. Then the fluorescence was
analyzed under microscope using appropriate filters.
RT-PCR Analysis
mRNA was extracted using Trizol solution (LucernaChem,
Tri Reagent, TR-118-200) and then 800 ng of mRNA in a
20 µl reaction were used for cDNA synthesis using oligo
(dT)18 according to the manufacturer’s procedure (Roche
Applied Science, First strand cDNA synthesis kit for RT-PCR
#04897030001). The equivalent of 2–20 ng original total RNA
was used for quantitative PCR amplification using the 2 x
brilliant SYBR Green QPCR Master Mix (Agilent Technologies,
#600548) and 0.5 mM forward and reverse primer pairs, designed
to span an intron of the target gene. RPE65 was detected using
forward primer (5′-CCCTTTTGCACAAGTTTGAC-3′)
and reverse primer (5′-AAAGCACAGGTGCCAAATTC-
3′), bFGF was detected using forward primer (5′-
AGCGGCTGTACTGCAAAAAC-3′) and reverse primer
(5′-AGCCAGGTAACGGTTAGCAC-3′). Normalization was
performed with the GAPDH expression detected using forward
primer (5′-ATGCCTCCTGCACCACCAAC-3′) and reverse
primer (5′-CGCCTGCTTCACCACCTTCT-3′). Triplicate Real-
time PCR was performed in the Light Cycler 480 from Roche,
using the following cycling conditions: 1 cycle of denaturation at
95◦C for 10 min, followed by 50 cycles of denaturation at 95◦C
for 10 s, annealing at 57◦C for 45 s without any extension for all
qPCR reactions.
Photoreceptor Outer Segment (POS)
Preparation and Fluosphere Opsonization
POS were prepared from freshly slaughtered cow eyes following
a protocol adapted from a previous study (Klettner et al.,
2011). Briefly, 12 retinas needed 10 ml homogenizer buffer (34%
sucrose, 65 mM NaCl, 2 mM MgCl2) and were vortexed for 2
min. The solution was then centrifuged 4 min at 3′800 rpm at
room temperature, allowing cell bodies to be pelleted and POS
to remain in solution due to the osmolarity of the buffer. The
supernatant was diluted in 2 volumes of HEPES 10 mM, gently
mixed and centrifuged again. The supernatant was discarded
and the pellet, constituted of POS, was resuspended in 5 ml of
10 mM HEPES and homogenized 30 times through a 23 gauge
canula. The protein concentration was assessed by the Micro
BCA protein stain assay (Perbio Science Switzerland SA, 23235).
Yellow-green fluorescent FluoSpheres R© beads (Molecular
Probes, F-8853) of 2.0 µm diameter were opsonized by POS.
FluoSpheres were prepared with a ratio of 0.5mg of POS per 43.3
million beads (10 µl of commercial solution), mixed together
for 1 h on a rotary wheel at 4◦C in the dark. Coated beads
were separated by centrifugation at 6,600 rpm for 20 min at
4◦C. Then the pellet was washed twice, using sterile 0.9% NaCl
solution, and resuspended in 100 µl of this latter solution. POS-
coated Fluospheres were used for phagocytosis assay just after
preparation.
Fluosphere and POS Phagocytosis Assay
Twenty million beads of FluoSpheres alone or coated with
POS were added per well in 12-well plate cultures (Milian SA,
TP-92412) of ARPE19 cells treated with various compounds
(see cell culture conditions section). After 16 h of incubation,
the cells were washed 6 times with PBS to remove all
unabsorbed FluoSpheres. Nuclei were stained with Hoechst
dye (Sigma, B2261-25 MG, 1/2000) in normal medium during
5 min at 37◦C. After 3 more washes with PBS, the cells
were fixed using 4% paraformaldehyde (Acros Orga, 41678-
0010) solution for 30 min at room temperature and then
washed another 3 times with PBS and finally mounted
on glass slides with one drop of citifluor (Citifluor Ltd,
AF1). Finally, measurement of phagocytosis rate was done
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by microscopy analysis, the ratio between the area covered
by Fluospheres and the number of cell nuclei was calculated
with the Image J program for each picture (four squares per
condition).
Statistical Analysis
All results were expressed as means ± SEM of the indicated
number of experiments. Data were statistically analyzed using
Prism 6.0 software. Comparison of two groups was done by using
T-test analysis. For more than 2 groups, we first tested each
group of data for distribution normality using Shapiro-Wilk tests.
In case of normal distribution, we used a Welch’s ANOVA test
(one-way ANOVAwith unequal variances) followed by a post-hoc
Tukey-Kramer test to compare the different treatments. When
the distribution was not normal, we used a Kruskal-Wallis test
(non-parametric analog of the one-way ANOVA) to compare the
different treatments. p < 0.05 was chosen as the threshold for
statistical significance.
RESULTS
ARPE19 Cells Cultured on Transwell Filters
Display Polarized Features and Different
Kinase Activities
We first compared MAPK activities between ARPE19 cells
cultured on plastic and on laminin-coated transwell filters.
ARPE19 cells cultured on transwell filters showed polarized
features as shown by the expression of tight junction zonula
occludens (ZO-1) and by the homogeneity of cell size
(Figure 1A). Moreover, transepithelial resistance (TER) was
similar to that previously described by Dunn et al. (1996 data
not shown). As described in a previous study, gene expression
is very different when ARPE19 cells are polarized (Turowski
et al., 2004). Therefore, we analyzed the activities of the three
major kinases, including p38, JNKp46/54 and ERK1/2, in both
conditions. Interestingly, no significant difference was observed
FIGURE 1 | Polarization of ARPE19 cells by culturing them on
transwells modifies cell morphology and basal kinase activities.
ARPE19 cells were cultured either on plastic or on laminin-coated transwell
filters as described in material and methods. (A) ZO-1 immunofluorescence on
ARPE19 cells cultured on both distinct conditions. (B) Quantification of basal
MAPKs activation by western blot analysis of the phosphorylated and the
non-phosphorylated p38, JNK p46/p54 and ERK1/2 after culture in both
conditions. Results are expressed as mean ± SEM of 5 experiments with
100% fixed for the culture on well; *p < 0.0012.
for p38, and JNKp46/54 activities, whereas ERK1/2 activity is
increased 2-fold when ARPE19 cells are cultured on transwell
filters (Figure 1B).
Short- and Long-Term Effects of
Bis-Retinoid A2E on MAPK Activities
We analyzed the effect of A2E compound on polarized ARPE19
cells. As previously shown by Sparrow et al., A2E induces cell
death (Sparrow et al., 1999). In our conditions, 5µMA2E already
induces PI-positive cells after 5 h, with a significantly stronger
effect after 72 h of exposure (5 h: 15.0 ± 2.1 vs. 72 h: 54.5 ±
6.9, p < 0.02). Interestingly, if the medium is changed and cells
cultured for another 72 h period, A2E is still present in the cells
as shown by A2E auto-fluorescence (excitation at 488 nm and
emission at 515–540 nm); in fact in this condition, we observed
more cell death as shown by PI-positive cells (Figure 2) (72 +
72 h: 204.7 ± 20.2, p < 0.02). We then assessed short- and long-
term effects of toxic A2E compound on kinase activities. Figure 3
shows a rapid activation of JNKp46/54 within 15 min, while
little or no change was observed for p38 and ERK1/2 activities.
On the other hand, when we exposed cells to A2E for a period
of 72 h, with a 72 h period of recovery (medium is changed
after 72 h), we observed a marked decrease of ERK1/2 activity
(more than 50%) while no modification of JNKp46/54 and p38
was observed (Figure 4A). The A2E-induced decrease of ERK1/2
activity was also measured when ARPE19 cells were exposed to
the compound during a lesser period of time (24, 48 h) (data not
shown) and when A2E was added to non-polarized ARPE19 cells
(Supplementary Figure 1A).
A similar decrease of ERK1/2 activity is also observed
in isolated mouse RPE cells cultured in transwell filters
(Supplementary Figure 1B) in the related conditions (Figure 4B).
Interestingly, the expression of RPE65 protein, a marker of
RPE cells, is also decreased to about 50% after A2E treatment
(Figure 4B). In ARPE19 cells, RPE65 protein is not detectable,
in non-polarized or polarized cells, while an important level
of mRNA is evident (Maeda et al., 2013 and data not shown).
However, when we tested the effect of A2E on RPE65 mRNA
expression to analyze a potential transcriptional effect of A2E,
we were able to detect a significant decrease due to the toxic
compound in polarized ARPE19 cells (Figure 4C).
A2E Drastically Increases bFGF MRNA
Expression through a Decrease of ERK1/2
Pathway
Because of the implication of bFGF in ARMD we were
interested in assessing the effect of A2E on this molecule. We
observed a strong and significant increase of bFGF mRNA
expression after exposure to A2E (7-fold increase). In parallel,
the exposure of polarized ARPE19 cells to U0126, an inhibitor
of ERK1/2 pathway, led to a significant increase of bFGF mRNA
(Figure 5A). Analyses using Cycloheximide and Actinomycin D
clearly showed that A2E acts directly at the transcriptional level
(Supplementary Figure 2). When we tested the bFGF protein
expression, we did not observe any modification; we even found
a slight decrease (Figure 5B). This latter result led us to believe
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FIGURE 2 | A2E induces cell death in polarized ARPE19 cells. Autofluorescence (excitation at 488 nm and emission at 515–540 nm) of A2E was used to show
the molecule accumulation into cells. Different periods of time were tested, in details 5, 72, and 72 h followed by 72 h of recovery. HOECHST/PI assay was done for
each condition in order to show the cell death induced by A2E. Results are representative of 3 experiments.
FIGURE 3 | A2E induces a rapid activation of JNKp46/p54 phosphorylation in polarized ARPE19 cells. ARPE19 cells were cultured as described in material
and methods before treatment with 5 µM A2E for different periods of time. Quantifications of MAPK activation by Western Blot analysis of the phosphorylated and the
non-phosphorylated p38, JNK p46/p54, and ERK1/2 after different times of A2E incubation. Results were representative of 3–4 experiments (n = 3–4).
that bFGF is secreted from ARPE19 cells. In order to evaluate
this hypothesis, we setup an AlphaLisa to detect bFGF protein in
the medium of cultured ARPE19 cells (Supplementary Figure 3).
The principle of the assay is described in Supplementary Figure
3A with a standard curve using recombinant bFGF illustrated
in Supplementary Figure 3B. We were able to measure bFGF
at a very low level (50–100 ng) with a good assay linearity up
to 3 logarithms. The bFGF protein was detectable by AlphaLisa
assay in protein lysates (PS), and in medium samples from
cells incubated with A2E (MS), but not in medium samples
from control cells incubated with EtOH (Supplementary Figure
3D). Quantification of bFGF protein present in protein lysates
(83 ± 7.8 for control and 77 ± 8.0 for A2E treated ARPE19
cells) correlates withWestern Blot analysis (Figure 5B), knowing
that AlphaLisa did not differentiate between diverse bFGF forms.
The very low level of bFGF highlighted a technical problem of
detection, which is probably due to the short half- life or to the
sticky property of bFGF; to confirm bFGF secretion we assessed
bFGF expression by immunostaining the protein in ARPE19 cells
treated or not with A2E, but not permeabilized with Triton-X.
Figure 5C showed an increase of bFGF at the surface of the cell
membrane that confirms the increased trend of bFGF secretion
after A2E treatment. In addition, as ERK1/2 has been suggested
to modulate type 1 collagen, we tested the effect of A2E on
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FIGURE 4 | A2E decreases the activity of ERK1/2 in polarized ARPE19 and isolated mouse RPE cells, and decreases RPE65 protein expression via
mRNA down-regulation. ARPE19 and isolated mouse RPE cells were cultured as described in material and methods before treatment with 5 µM A2E for 72 h
following by 72 h recovery. (A) Western blot analysis of polarized ARPE19 cells shows the phosphorylated and non-phosphorylated forms of different MAPK, namely
p38, JNK p46/54 and ERK1/2 after A2E treatment (72/72 h recovery). Results are expressed as mean ± SEM of 2–3 experiments (n = 6–9) with 100% fixed for the
untreated cells; *p < 0.01. (B)Western blot analysis of isolated mouse RPE cells shows the decrease of ERK1/2 phosphorylation and the decrease of RPE65 proteins
expression. Quantification of ratio pERK1/2/ERK1/2 and RPE65/Tubulin are expressed as mean ± SEM of 3 distinct experiments with 100% fixed for the untreated
cells; *p < 0.01 (C) Quantitative PCR was done to show the level of RPE65 mRNA in ARPE19 cells. Quantification of the mRNA RPE65/GAPDH ratio is expressed as
mean ± SEM of 4 experiments (n = 11–13) with 100% fixed for the untreated cells; ***p < 0.0001.
the expression of type 1 collagen protein and interestingly, A2E
induces a strong increase of this structural protein (Figure 5D).
Recombinant bFGF Reduces ERK1/2
Activity in Polarized ARPE19 Cells
We then tested the effect of recombinant bFGF on ERK1/2
pathway and we observed a rapid decrease of ERK1/2
phosphorylation. After only 30 min bFGF is able to reduce
by 50% the activity of ERK1/2 (Figure 6A). When we used
BGJ398, an inhibitor of the FGF receptor, we totally blocked the
bFGF-induced decrease of ERK1/2 phosphorylation (Figure 6B).
Interestingly even in absence of bFGF, but in the presence of the
inhibitor, we observed an increase of ERK1/2 activity, probably
due to the presence of FGF in the culture medium. In addition,
inhibition of the bFGF pathway by BGJ398 did not modify A2E
effect on ERK1/2 activity (Supplementary Figure 2B). This result
shows that A2E effect on ERK1/2 activity is independent of bFGF,
but could be sustained by bFGF.
A2E and bFGF Increase Photoreceptor
Phagocytosis by ARPE19 Cells
We tested the effect of A2E on the ARPE19 phagocytosis.
Exposure of ARPE19 cells to A2E significantly increased the
phagocytosis of fluorescent microspheres, while the ERK1/2
inhibitor did not affect this phagocytic activity. Recombinant
bFGF also induces an increase (up to 2-fold) of phagocytosis.
As control, we used photodynamic treatment mediated by
Merocyanine 540 (MC540) that decreased the phagocytosis
of FluoSpheres by 80% (Figure 7A). When the phagocytosis
experiment was performed with POS-coated FluoSpheres, we
observed an effect only when the cells were exposed to bFGF
(50% of increase), while both A2E and ERK1/2 inhibitor did not
affect the phagocytic function. In the meantime, MC540, used
as control, gave similar results and drastically decreased ARPE19
phagocytosis (Figure 7B).
DISCUSSION
We first showed in this study that the basal level of MAPK
activities is different when ARPE19 cells are polarized. As
mentioned, and accepted now by the scientific community
working on RPE, the polarization of ARPE19 cells when cultured
on filters is essential to preserve the function and gene expression
of these cells. We then confirmed previous studies showing the
toxic effect of the lipofuscin fluorophore A2E treated (Sparrow
et al., 2000) or not (Sparrow et al., 1999) with blue light. Indeed,
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FIGURE 5 | A2E induces an increase of bFGF mRNA at transcriptional level in polarized ARPE19 cells. ARPE19 were cultured as described in material and
methods before treatment with 5 µM A2E for 48 h. (A) Quantitative PCR shows the different mRNA levels of bFGF in ARPE19 cells treated or not with 5 µM A2E or 5
µM U0126. Quantification of the mRNA bFGF/GAPDH ratio is expressed as mean ± SEM of 3 experiments (n = 7–14) with 100% fixed for the untreated cells; **p <
0.007, ***p < 0.0001. (B) Western blot shows the expression level of bFGF (nuclear and secreted forms). Positive control was done using recombinant bFGF [SIGMA,
F0291]. Quantification of the bFGF/TUBULIN ratio was expressed as mean ± SEM of 3 experiments (n = 9) with 100% fixed for the untreated cells; *p < 0.01.
(C) Immunostaining of bFGF protein in non-permeabilized polarized ARPE19 cells after 48 h of exposure to 5 µM A2E, result is representative of two distinct
experiments. (D) Western blot shows the expression level of type 1 COLLAGEN normalized by TUBULIN. Quantification of the COLLAGEN1/TUBULIN ratio was
expressed as mean ± SEM of 3 experiments (n = 9) with 100% fixed for the untreated cells.
we used a lower concentration (5 µM) and longer incubation
period (72 or 72 h with 72 h of recovery) to completely load
polarized ARPE19 cells and induce cell death (Figure 2).
When analyzing kinase activities, we observed a rapid (30
min) and significant activation of the JNK pathway after
ARPE19 exposure to A2E, while Westlund et al. did not
indicate any activation of this pathway in absence of blue-light
photo-oxidation. Besides, cell culture conditions (non-polarized
ARPE19 cells), concentration of A2E used (10–100µM) and time
of exposure to the toxic compound were very different from our
study and could explain the difference in the results (Westlund
et al., 2009). As little A2E is present in the cells after a short-term
incubation (Figure 2, 5 h), we could think that the A2E effect on
JNK activation is principally due to the triggering of a membrane
protein or a receptor expressed at the surface of ARPE19 cells
that further analyses would identify. Recently, Fernandes et al.
showed that A2E induced secretion of IL-8 pro-inflammatory
cytokines via p38 activation (Fernandes et al., 2008), but only
when photo-oxidation is induced by blue light treatment. As it
was the case in our study, no short-term activation of the p38
pathway was observed in presence of A2E.
Long-term incubation (72 h loading and 72 h recovery) of
polarized ARPE19 cells with A2E showed an accumulation of
the fluorophore in cells concomitant with cell death (Figure 2);
we also observed a significant decrease of ERK1/2 activity
which can be reproduced in isolated mouse RPE cells cultured
on filters (Figures 4A,B). We previously showed that UVs
induce a decrease of the ERK1/2 pathway in ARPE19 cells
and we suggested that this could partially explain the UV-
induced ARPE19 cell death (Roduit and Schorderet, 2008).
Studies have shown that inhibition of the Ras/Raf/MEK/ERK
pathway reduces RPE cell proliferation (Hecquet et al., 2002)
while other studies have shown that canolol protects ARPE19
cells from oxidative damage probably also through the ERK1/2-
mediated pathway (Dong et al., 2011) or that H2O2 decreases
cell viability by activating ERK1/2 (Garg and Chang, 2003).
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FIGURE 6 | Impact of bFGF on ERK1/2 activity in polarized ARPE19
cells. ARPE19 cells were cultured as described in material and methods
before treatment with 200 ng/ml of bFGF for 30 respectively 60 min. (A)
Western blot analysis shows the phosphorylation change of ERK1/2 after
bFGF. Quantification of pERK1/2/ERK1/2 ratio is expressed as mean ± SEM
of 3-4 experiments (n = 9–12) with 100% fixed for the untreated cells; **p <
0.005. (B) Inhibition of bFGF receptor, by BGJ398, blocks the bFGF-induced
down regulation of ERK1/2 activity, results are expressed as mean ± SEM of
3-4 experiments (n = 9–12) with 100% fixed for the untreated cells; *p <
0.001 and **p < 0.0002.
Therefore, the opposing role of ERK1/2 in neurons is difficult
to clearly understand because it could be due to the duration of
ERK1/2 signaling, the model studied or to associations with other
molecular players (Subramaniam and Unsicker, 2010).
Interestingly, we showed that the level of RPE65, a marker
of RPE cells, is significantly decreased when isolated mouse
RPE cells are exposed to A2E for a long period (Figure 4B).
This result together with the fact that A2E drastically decreases
RPE65 mRNA expression in polarized ARPE19 cells (Figure 4C),
suggests that A2E not only inhibits RPE65 activity by directly
binding the isomerohydrolase (Moiseyev et al., 2010), but
also by regulating its expression at the transcriptional level.
The analysis of the RPE65 promoter suggests a potential AP-
1 sequence (Nicoletti et al., 1998) that could explain this
result.
Studies by Chaudhary and Avioli have clearly shown in
mouse osteoblast-like ME3T3-E1 cells, that ERK1/2 inhibitors
(PD98059 and U0126) increase the mRNA expression of type
1 collagen, while an ERK1/2 activator (okadaic acid) inhibits
its expression (Chaudhary and Avioli, 2000). These results are
in accordance with our result showing the increase of type 1
Collagen protein expression after long-term exposure to A2E,
which induces a decrease in ERK1/2 activity. In addition, some
studies have shown that RPE cells cultured on type 1 Collagen
FIGURE 7 | A2E increases phagocytosis in ARPE19 via bFGF. ARPE19
cells were cultured as described in material and methods for phagocytosis
assay. Merocyanine 540 (MC540), an exogenous photosensitizer able to lower
phagocytic activity was used as control and detailed in material and methods.
(A) Non-specific phagocytosis of synthetic fluorescent beads was performed
in absence or presence of 5 µM A2E, 5 µM U0126, 200 ng/ml bFGF or 4.5
µM MC540. Quantification of the ratio between area covered by fluorospheres
and the number of cell nuclei is expressed as mean ± SEM of 3–12
experiments (n = 9–36) with 100% fixed for the untreated cells; *p < 0.0003
and ***p < 0.0001. (B) Photoreceptor outer segments (POS) coated with
fluorospheres were used to analyze the phagocytic activity of APRE19 in
absence or presence of 5 µM A2E, 5 µM U0126, 200 ng/ml bFGF or 4.5 µM
MC540. Quantification of the ratio between the area covered by fluorospheres
and the number of cell nuclei is expressed as mean ± SEM of 4–7
experiments (n = 12–27) with 100% fixed for the untreated cells.; *p < 0.005
and ***p < 0.0001.
significantly increase the levels of various angiogenic factors,
including bFGF and VEGF. In our study, the increase of bFGF,
observed after exposure to A2E (Figure 5A), did not result from
the increase of type 1 Collagen, which then induced the increase
of the angiogenic factor because when we inhibited protein
synthesis with cycloheximide, we still detected a significant
increase of bFGF mRNA. This latter result and the inhibition
of A2E-induced increase of bFGF mRNA by actinomycin D
preferentially suggest an inhibitory effect of ERK1/2 on its targets.
Results showing an inhibitory effect of bFGF on the ERK1/2
pathway (Figure 6A) were very surprising because numerous
studies showed opposite effects. The high concentration of bFGF
recombinant (200 ng/ml instead of 20 ng/ml in most studies)
may partially explain this discrepancy, as well as experiments
performed in non-polarized ARPE19 cells. Moreover, inhibition
of bFGF receptor, by BGJ398, clearly abolishes the bFGF effect
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on ERK1/2 activity (Figure 6B). In addition, the inhibitor alone
increases the basal ERK1/2 activity (without bFGF), probably by
blocking FGF activators present in the serum. This latter result
suggests that bFGF could decrease ERK1/2 activity depending on
its concentration and cell culture conditions used. A recent study,
performed by Ferguson et al. support our results; indeed they
showed that deprivation of bFGF from growth media leads to an
increase of RPE-specific proteins, including RPE65, that mediate
the differentiation of human embryonic stem cells (hESC) into
RPE cells (Ferguson et al., 2015).
In order to test the bFGF secretion, we developed a robust
AlphaLisa assay with high sensitivity and a dynamic range of
three logarithms. The combinations of strong signals (S) and
low background (B) result in very high S:B ratios, even at very
low bFGF concentrations (Supplementary Figure 3). Despite
the strength of the assay, we were able to detect only a small
increase of bFGF in the medium of ARPE19 cells exposed to
A2E. Previous studies already mentioned the secretion of bFGF
by ARPE19 cells (Mousa and Lorelli, 1999); we confirm herein
that A2E, via ERK1/2 down-regulation, induces the secretion of
bFGF in polarized ARPE19 cells. This angiogenic factor is found
at a high concentration in neovascular tissue in ARMD and is up-
regulated in laser-induced choroidal neovascularization (CNV)
(Rosenthal et al., 2005) and therefore could be an important
factor in ARMD.
Lipofuscin, principally composed of A2E, is formed by the
condensation of all-trans retinal and phosphatidylethanolamine;
its accumulation is due to incomplete digestion of outer segments
(OS) by RPE (Wolf, 2003). A2E-loaded RPE-J and d407-RPE
cells internalized similar amounts of OS to control RPE cells,
but prevented the clearance of OS via an impairment in lipid
degradation (Finnemann et al., 2002). Indeed, A2E inhibits
phagocytosis via an oxidative process involving mitochondria
only when RPE cells are cultured in physiological concentrations
of glucose (5.5mM, instead of 25mMpresent in the RPEmedium
used in most studies; Vives-Bauza et al., 2008). When we tested
the effect of A2E on phagocytic RPE function, we observed
a small but significant increase of non-specific phagocytosis
(FITC-beads), while specific phagocytosis (opsonized POS) is
slightly but non-significantly increased (Figure 7). The difference
observed in comparison with other studies could be due to
the incubation time we used in our protocol (24 h) or could
be specific to ARPE19 cells. Interestingly, bFGF is able to
increase both, the non-specific and specific phagocytosis. This
latter result is in accordance with the study of McLaren et
al. showing that bFGF enhanced phagocytosis in RPE cells
isolated from normal rats (McLaren and Inana, 1997). As internal
control, we used the photodynamic treatment mediated by
merocyanine 540, and we were able to reproduce its inhibitory
effect on phagocytosis (Olchawa et al., 2010). We hypothesize
that A2E induces, via the ERK1/2 pathway, an increase of bFGF
mRNA and subsequently a secretion of the protein, which could
then have a paracrine effect on phagocytosis depending on its
concentration. A2E, as well as U0126, induces an increase in
bFGF mRNA when cells are exposed to A2E or to U0126 for
48 h, but fails to induce enough bFGF protein (incubation
for 24 h with A2E for phagocytosis experiment) to impact
the phagocytic function. Analysis of the bFGF level in mouse
models with high A2E levels (ABCA4−/−) or in the retina of
ARMD patients will be interesting in order to confirm this
hypothesis. This will open a new therapeutic field to treat
ARMD.
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